Erinacine A and related cyathane diterpenoids: Molecular diversity and mechanisms underlying their neuroprotection and anticancer activities

• Published in: Pharmacological research Vol. 159; p. 104953
• Main Authors: Bailly, Christian, Gao, Jin-Ming
• Format: Journal Article
• Language: English
• Published: Elsevier Ltd 01-09-2020
• Subjects: Apoptosis; Cancer therapy; Cyathane diterpene; Cyathin; Erinacine A; Natural products; Cyathane diterpene; Scabronine M (CID: 57404323); NGF; Cyathin; Cyathin Q (CID: 127026239); Cyahookerin C (CID: 145720985); Natural products; Cancer therapy; ROS; Erinacin A (CID: 10410568); iNOS; Erinacine A; Apoptosis
• ISSN: 1043-6618; 1096-1186
• DOI: 10.1016/j.phrs.2020.104953

[Display omitted]
•Over 170 cyathane diterpenes have been isolated from diverse fungi.•Many cyathanes display anti-inflammatory and neuroprotection effects.•Erinacine A and cyathins R and Q show significant antitumor properties in vivo.•Antitumor cyathanes could act by modulating the actin cytoskeleton.
The presence of a fused 5/6/7 tricyclic core characterizes the group of cyathane diterpene natural products, that include more than 170 compounds, isolated from fungi such as Cyathus africanus and Hericium erinaceus. These compounds have a common biosynthetic precursor (cyatha-3,12-diene) and can be produced bio- or hemi-synthetically, or via total syntheses. Cyathane diterpenes display a range of pharmacological properties, including anti-inflammatory (possibly through binding to the iNOS protein) and neuroprotective effects. Many cyathanes like cyahookerin C, cyathin Q and cyafranines B and G can stimulate neurite outgrowth in cells, whereas conversely a few molecules (such as scabronine M) inhibit NGF-stimulated neurite outgrowth. The main anticancer cyathanes are erinacine A and cyathins Q and R, with a capacity to trigger cancer cell death dependent on the production of reactive oxygen species (ROS). These compounds, active both in vitro and in vivo, activate different signaling pathways in tumor cells to induce apoptosis (and autophagy) and to upregulate the expression of several proteins implicated in the organization and functioning of the actin cytoskeleton. An analysis of the functional analogy between erinacine A and other natural products known to interfere with the actin network in a ROS-dependent manner (notably cucurbitacin B) further supports the idea that erinacine A functions as a perturbator of the cytoskeleton organization. Collectively, we provide an overview of the molecular diversity of cyathane diterpenes and the main mechanisms of action of the lead compounds, with the objective to encourage further research with these fungal products. The anticancer potential of erinacine A deserves further attention but it will be necessary to better characterize the implicated targets and signaling pathways.